943830-79-3

Usage

Uses

Used in Pharmaceutical Synthesis:
3-bromo-6-chloro-2-fluoroBenzonitrile is used as a key intermediate in the synthesis of pharmaceuticals for its unique properties and reactivity. It aids in the development of new drugs with improved therapeutic effects.
Used in Agrochemical Production:
In the agrochemical industry, 3-bromo-6-chloro-2-fluoroBenzonitrile is utilized as a building block for the creation of new compounds with potential applications in pest control and crop protection.
Used in Fine Chemicals Production:
3-bromo-6-chloro-2-fluoroBenzonitrile is employed in the production of fine chemicals, where its versatile nature allows for the creation of a wide range of specialized organic molecules for various applications.
Used in Organic Compounds Synthesis:
As a versatile building block, 3-bromo-6-chloro-2-fluoroBenzonitrile is used in the synthesis of other organic compounds, contributing to the advancement of chemical research and the development of new materials.

Upstream product

• 1996-29-8 1-bromo-4-chloro-2-fluorobenzene 
• 886615-30-1 3-bromo- 6-chloro-2-fluorobenzaldehyde 

Relevant academic research and scientific papers

QUINAZOLINYL-INDAZOLE DERIVATIVES AND THEIR USE AS INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION

Compounds of Formula I, including pharmaceutically acceptable salts thereof, and compositions and methods for treating human immunodeficiency virus (HIV) infection are set forth: Formula (I):

INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION

Compounds of Formula (I), including pharmaceutically acceptable salts thereof, and compositions and methods for treating human immunodeficiency virus (HIV) infection are set forth.

INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION

Compounds and pharmaceutically acceptable salts thereof, and compositions and methods for treating human immunodeficiency virus (HIV) infection are set forth.

INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION

Compounds of Formula (I), including pharmaceutically acceptable salts thereof, and compositions and methods for treating human immunodeficiency virus (HIV) infection are set forth.

INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION

Compounds of Formula (I), including pharmaceutically acceptable salts thereof, and compositions and methods for treating human immunodeficiency virus (HIV) infection are set forth:

INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION

The compounds depicted below, and pharmaceutically acceptable salts thereof, and compositions and methods for treating human immunodeficiency virus (HIV) infection are set forth (Formulae I or II).

INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION

The compound (I) and pharmaceutically acceptable salts thereof, and compositions and methods for treating human immunodeficiency virus (HIV) infection are set forth.

PYRIDO[2,3-D]PYRIMIDINE DERIVATIVES AS INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION

The compound and pharmaceutically acceptable salts thereof, and compositions and methods for treating human immunodeficiency virus (HIV) infection are set forth:

METHODS AND INTERMEDIATES FOR PREPARING A THERAPEUTIC COMPOUND USEFUL IN THE TREATMENT OF RETROVIRIDAE VIRAL INFECTION

The present disclosure relates to methods and intermediates useful for preparing a compound of formula (I): (I) or a co-crystal, solvate, salt or combination thereof.

4-OXO-3,4-DIHYDROQUINAZOLINE COMPOUNDS AS INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION

Compounds of Formula (I), including pharmaceutically acceptable salts thereof, and compositions and methods for treating human immunodeficiency virus (HIV) infection are set forth: Formula (I):